Why is Colinz Labs falling/rising?

As of 28-Jul, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at 47.17, which reflects a decrease of 0.96 or 1.99%. The stock has underperformed its sector by 2.07% today and has been on a consecutive downward trend for the last five days, resulting in a significant drop of 12.36% over that period. Additionally, the stock's performance over the past year shows a return of -29.60%, indicating a weak long-term fundamental strength with a negative compound annual growth rate (CAGR) of -2.96% in net sales over the last five years. The company's ability to service its debt is also concerning, with a poor EBIT to Interest ratio of 0.36, and a low return on equity of 4.40% suggests limited profitability.
In the broader market context, the stock's short-term performance has been notably worse than the benchmark, with the Sensex declining only 1.59% over the same week. This underperformance is compounded by a significant drop in investor participation, as evidenced by a 99.47% decrease in delivery volume compared to the five-day average. While the stock is trading at a discount compared to its peers' average historical valuations, the overall sentiment remains negative due to flat results and a high PEG ratio of 10.6, indicating that the stock may be overvalued relative to its earnings growth prospects.